ClinicaSpace.com
Clinical Research
News & Careers
 
Search the Site
    
 
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login           Employers:  Register | Login   


By Industry | By Industry Segment | By Services and Suppliers | By Location | Profile Search
 Company Profile

 

Geron Corporation 

230 Constitution Drive

Menlo Park  California  94025  U.S.A.
Phone: 650-473-7700 Fax: 650-473-7750


SEARCH JOBS


Industry
Biotechnology


Collaborations

Intergen Company 





 Company News
Geron Corporation (GERN) Analyst Report: High Potential High Risk Biopharmaceutical Firm Seeking To Advance Novel Innovative Cancer Treatment For Myeloid Malignancies By BrokerBank Securities, Inc. 4/7/2014 9:47:36 AM    More...
Geron Corporation (GERN) Says FDA Halts Patient Enrollment In Another Cancer Trial 3/20/2014 7:29:54 AM    More...
Geron Corporation (GERN) Tanks As FDA Halts Development Of Blood Disorder Drug 3/12/2014 7:35:27 AM    More...
Geron Corporation (GERN) Soars After Study Shows Bone Marrow Drug's Benefit 12/6/2013 7:40:27 AM    More...
Researchers Note Cautions About Geron Corporation (GERN) Drug Imetelstat 11/11/2013 8:31:25 AM    More...
Geron Corporation (GERN) Skyrockets as Cancer Drug is Highly Effective in Trial, Shares Up +44.72% @ Market Close (November 7, 2013) 11/7/2013 8:30:43 AM    More...
Asterias Biotherapeutics, Inc., a Subsidiary of BioTime (BTX), Acquires Geron Corporation (GERN)’s Embryonic Stem Cell Assets 10/1/2013 10:51:31 AM    More...
BioTime (BTX) Signs Definitive Agreement With Geron Corporation (GERN) Regarding Stem Cell Assets 1/7/2013 10:09:04 AM    More...
Geron Corporation (GERN) Ends Brain Cancer Drug Study, Cuts 43 Jobs 12/4/2012 7:37:22 AM    More...
Ex-Geron Corporation (GERN) CEO Launches Effort to Revive Lost Stem Cell Program 10/25/2012 9:07:17 AM    More...
12345678910...